Varney tells AJMC that analyses found unregulated peptides often hold just 5% to 75% of the labeled dose, and nobody checks them before patients inject.
Recap by typeshit. Full story at The American Journal of Managed Care.
Dr Bajekal flags that people on Mounjaro, semaglutide or Wegovy should talk it through with their doctor ahead of an operation.
The Form 483 cites microbial growth in a clean hood, reversed cleanroom air pressure and active ingredients marked for research use only. Check which pharmacy filled your vial.
One study cited by @fittrwithsquats put the risk of non-scarring hair loss about 40% higher with GLP-1 use, mostly telogen effluvium. Nail findings are less consistent.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Horek told KXAN he went on Wegovy hoping to drop a few stubborn pounds. Months later his story took a turn worth reading in full.
Some studies point to lower risk of certain cancers like breast cancer, but other research suggests the effect may fade over time.
Loading…